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HIV and drugs: a common, common-sense agenda for 2016
2016 is set to be a historic year for people living with 
and aﬀ ected by HIV and people who use drugs. The 
UN General Assembly Special Session (UNGASS) 
on drugs (April 19–21, 2016; New York, NY, USA), 
provides a rare occasion to review critically the global 
drug-control system and to advance alternatives that 
are balanced, evidence-informed, fair, public health-
oriented, and rooted in human rights. The UN Secretary-
General Ban Ki-moon urged that the Special Session 
“considers all options”.1 The UN High-Level Meeting on 
AIDS (June 8–10, 2016; New York, NY, USA) oﬀ ers an 
opportunity to commit to concrete steps to fast-track 
the response to ending the AIDS epidemic, including 
progressive approaches to drugs policy.
Evidence of disproportionately high rates of HIV 
among people who inject drugs has been apparent since 
the beginning of the AIDS epidemic, and evidence of a 
higher burden of the disease among some people who 
use drugs by other means (mainly those who smoke 
stimulants) has become apparent.  Individuals who inject 
drugs are 28 times more likely to acquire HIV than are the 
general population.2 Outside sub-Saharan Africa, 30% of 
new cases of HIV infection are in people who inject drugs, 
and in some countries, more than 90% of individuals 
who inject drugs are also living with hepatitis C.3
Punitive laws, policies, and practices obstruct access to 
life-saving harm-reduction services—eg, sterile needles 
and syringes, opioid substitution therapy, voluntary 
HIV testing, antiretroviral therapy, and naloxone for 
overdose management and reversal. Legal approaches 
that criminalise and dehumanise people who use drugs 
constitute the primary drivers of both the HIV and 
hepatitis C epidemics amongst this community. Harm 
reduction works in preventing new HIV infections 
among people who inject drugs, but it is not routinely 
accessible;4 chemsex (the use of psychoactive substances 
to extend sexual activities) presents continued 
challenges to harm reduction.5
In 2016, we call on the international community to join 
the AIDS and drug-law reform movements to advance a 
six-point agenda to ensure aligned policy on AIDS, drugs, 
human rights, public health, and criminal justice (panel). 
The international community has embraced the 
target of ending AIDS as a public health threat by 2030. 
This goal will only be reached by adopting public health 
and human rights-based approaches to all policies and 
programmes relating to drug use. Now is the time to 
work together to ensure that this six-point agenda is 
reﬂ ected in the outcome documents of the 2016 UN 
meetings on drugs and AIDS and to ensure that we stop 
leaving people who use drugs behind in our eﬀ orts to 
ensure health, human rights, and wellbeing for all.
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Panel: A progressive policy agenda for public health and drug use
• Put the health, wellbeing, human rights, dignity, and security of people who use drugs 
at the centre of international and national drug policy.
• Ensure that drug policy is informed by evidence of what works, in particular in relation 
to access to integrated harm reduction, which includes services for HIV, tuberculosis, 
viral hepatitis, and sexually-transmitted infections, in addition to non-coercive drug 
treatment, as outlined in UN guidance.6 Holistic, people-centred services—tailored to 
the needs and realities of speciﬁ c groups of people who use drugs (eg, women, men 
who have sex with men, prisoners, young people)—need to be accessible and included 
in all universal health coverage packages.
• Treat people who use drugs as rights holders, who should neither be criminalised nor 
viewed as having a disorder purely on the basis of their drug use. Alternatives to 
criminalisation are needed—eg, decriminalisation, and stopping the incarceration of 
people for consumption and possession of drugs for personal use. Further, compulsory 
drug and HIV testing and drug treatment need to be replaced with voluntary schemes, 
including by providing access to community-based drug treatment and other 
harm-reduction services.
• Promote and protect the human rights of people who use drugs, including through 
renewed eﬀ orts at eliminating discrimination in health care, criminal justice, 
education, employment, legal services, and social protection settings, and through 
access to justice programmes.
• Actively empower and support drug users and people living with HIV, and 
organisations working with these populations, to participate eﬀ ectively in the 
governance and delivery of health and other services intended for people who use or 
inject drugs—eg, by supporting the establishment and adequate ﬁ nancing of such 
organisations, and by ensuring the representation of these organisations in bodies 
such as national AIDS councils.
• Signiﬁ cantly ramp up investments in harm-reduction programmes, including by 
redeploying resources from often ineﬀ ective punitive approaches, in the context of 
implementing the Sustainable Development Goals on health, equality, inclusion, 
and justice. 
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